<DOC>
	<DOCNO>NCT02537483</DOCNO>
	<brief_summary>The primary objective study compare efficacy , safety , tolerability IDP-120 Gel IDP-120 Component A , IDP-120 Component B , IDP-120 Vehicle Gel subject moderate severe acne vulgaris .</brief_summary>
	<brief_title>A Study Comparing Efficacy Safety IDP-120 Gel Treatment Acne Vulgaris</brief_title>
	<detailed_description>This multi-center , randomize , double-blind , vehicle-controlled , 12-week study design assess safety , tolerability , efficacy IDP-120 Gel comparison IDP-120 Component A , IDP-120 Component B , IDP-120 Vehicle Gel Weeks 2 , 4 , 8 , 12 subject moderate severe acne . IDP-120 gel topical treatment acne .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<criteria>Male female least 9 year age old Written verbal informed consent must obtain . Subject must score moderate severe Evaluator 's Global Severity assessment screen baseline visit Premenses females woman childbearing potential must negative urine pregnancy test screen baseline visit Subjects must willing comply study instruction return clinic require visit . Any dermatological condition face could interfere clinical evaluation Any underlying disease ( ) dermatological condition face require use interfere topical systemic therapy make evaluation lesion count inconclusive Subjects facial beard mustache could interfere study assessment Subjects unable communicate cooperate Investigator Subjects underlying disease Investigator deem uncontrolled pose concern subject 's safety participating study</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>